Inventor · disambiguated record
Nicholas Paul Kwiatkowski
Also filed as: KWIATKOWSKI NICHOLAS · KWIATKOWSKI NICHOLAS P · KWIATKOWSKI NICHOLAS PAUL
27 granted patents·9 pending applications·131 citations·filing 2006–2022
95Inventor score
Files withDANA FARBER CANCER INST INC31HARVARD COLLEGE2ANDERSON KENNETH C1GRAY NATHANAEL S1MAZITSCHEK RALPH1
Top patents by PatentIndex Score
36 records- 0197US11325910B2Inhibitors of cyclin-dependent kinasesDANA FARBER CANCER INST INC·Filed 2020·Granted May 10, 2022·8 cites·24 claims
- 0297US10550121B2Inhibitors of cyclin-dependent kinasesDANA FARBER CANCER INST INC·Filed 2016·Granted Feb 4, 2020·15 cites·10 claims
- 0394US11932625B2Inhibitors of cyclin-dependent kinase 12 (CDK12) and uses thereofDANA FARBER CANCER INST INC·Filed 2022·Granted Mar 19, 2024·3 cites·30 claims
- 0494US10870651B2Inhibitors of cyclin-dependent kinase 7 (CDK7)DANA FARBER CANCER INST INC·Filed 2015·Granted Dec 22, 2020·9 cites·36 claims
- 0592US11306070B2Inhibitors of cyclin-dependent kinase 12 (CDK12) and uses thereofDANA FARBER CANCER INST INC·Filed 2017·Granted Apr 19, 2022·8 cites·20 claims
- 0692US10787436B2Inhibitors of cyclin-dependent kinase 7 (CDK7)DANA FARBER CANCER INST INC·Filed 2018·Granted Sep 29, 2020·5 cites·37 claims
- 0792US10112927B2Inhibitors of cyclin-dependent kinase 7 (CDK7)DANA FARBER CANCER INST INC·Filed 2013·Granted Oct 30, 2018·19 cites·20 claims
- 0890US12098154B2Inhibitors of cyclin-dependent kinasesDANA FARBER CANCER INST INC·Filed 2022·Granted Sep 24, 2024·1 cites·37 claims
- 0990US8999289B2Treatment of protein degradation disordersANDERSON KENNETH C·Filed 2006·Granted Apr 7, 2015·16 cites·32 claims
- 1088US9464091B2Pyrimido-diazepinone kinase scaffold compounds and methods of treating disordersDANA FARBER CANCER INST INC·Filed 2016·Granted Oct 11, 2016·5 cites·14 claims
- 1187US9572854B2Treatment of protein degradation disordersHARVARD COLLEGE·Filed 2015·Granted Feb 21, 2017·6 cites·20 claims
- 1286US11142507B2Inhibitors of cyclin-dependent kinasesDANA FARBER CANCER INST INC·Filed 2016·Granted Oct 12, 2021·7 cites·26 claims
- 1386US9266890B2Pyrimido-diazepinone kinase scaffold compounds and methods of treating disordersGRAY NATHANAEL S·Filed 2010·Granted Feb 23, 2016·7 cites·3 claims
- 1486US8304451B2Histone deacetylase and tubulin deacetylase inhibitorsMAZITSCHEK RALPH·Filed 2007·Granted Nov 6, 2012·11 cites·31 claims
- 1585US12168663B2Inhibitors of cyclin-dependent kinase 7 (CDK7)DANA FARBER CANCER INST INC·Filed 2020·Granted Dec 17, 2024·1 cites·17 claims
- 1683US10172905B1Treatment of protein degradation disordersHARVARD COLLEGE·Filed 2017·Granted Jan 8, 2019·3 cites·20 claims
- 1781US10081639B2Pyrimido-diazepinone kinase scaffold compounds and methods of treating disordersDANA FARBER CANCER INST INC·Filed 2017·Granted Sep 25, 2018·2 cites·6 claims
- 1881US9701683B2Pyrimido-diazepinone kinase scaffold compounds and methods of treating disordersDANA FARBER CANCER INST INC·Filed 2016·Granted Jul 11, 2017·2 cites·6 claims
- 1978US10865204B2Degradation of cyclin-dependent kinase 4/6 (CDK4/6) by conjugation of CDK4/6 inhibitors with E3 ligase ligand and methods of useDANA FARBER CANCER INST INC·Filed 2017·Granted Dec 15, 2020·3 cites·30 claims
- 2072US11827636B2Degradation of cyclin-dependent kinase 8 (CDK8) by conjugation of CDK8 inhibitors with E3 ligase ligand and methods of useDANA FARBER CANCER INST INC·Filed 2021·Granted Nov 28, 2023·0 cites·16 claims
- 2167US10570154B2Pyrimido-diazepinone kinase scaffold compounds and methods of treating disordersDANA FARBER CANCER INST INC·Filed 2018·Granted Feb 25, 2020·0 cites·10 claims
- 2265US11247991B2Degradation of cyclin-dependent kinase 8 (CDK8) by conjugation of CDK8 inhibitors with E3 ligase ligand and methods of useDANA FARBER CANCER INST INC·Filed 2020·Granted Feb 15, 2022·0 cites·23 claims
- 2363US2022055998A1Inhibitors of cyclin-dependent kinasesDANA FARBER CANCER INST INC·Filed 2021·Application pending·0 cites
- 2456US12281126B2Inhibitors of cyclin-dependent kinase 7 and uses thereofDANA FARBER CANCER INST INC·Filed 2019·Granted Apr 22, 2025·0 cites·15 claims
- 2553US10865205B2Degradation of cyclin-dependent kinase 8 (CDK8) by conjugation of CDK8 inhibitors with E3 ligase ligand and methods of useDANA FARBER CANCER INST INC·Filed 2017·Granted Dec 15, 2020·0 cites·14 claims
- 2652US2024360104A1Transcriptional enhanced associated domain (tead) transcription factor inhibitors and uses thereofDANA FARBER CANCER INST INC·Filed 2022·Application pending·0 cites
- 2751US12491251B2Degraders of cyclin-dependent kinase 7 (CDK7) and uses thereofDANA FARBER CANCER INST INC·Filed 2020·Granted Dec 9, 2025·0 cites·25 claims
- 2851US2023242534A9Inhibitors of cyclin-dependent kinase 7 and uses thereofDANA FARBER CANCER INST INC·Filed 2020·Application pending·0 cites
- 2950US2024124406A1Inhibitors of transcriptional enhanced associate domain (tead) and uses thereofDANA FARBER CANCER INST INC·Filed 2021·Application pending·0 cites
- 3050US2023192607A1Transcriptional enhanced associate domain (tead) transcription factor inhibitors and uses thereofDANA FARBER CANCER INST INC·Filed 2020·Application pending·0 cites
- 3150US2022227734A1Degraders of cyclin-dependent kinase 12 (cdk12) and uses thereofDANA FARBER CANCER INST INC·Filed 2020·Application pending·0 cites
- 3249US12466809B2CDK2/5 degraders and uses thereofDANA FARBER CANCER INST INC·Filed 2020·Granted Nov 11, 2025·0 cites·27 claims
- 3348US2021230101A1Compounds for treating dengue virus infections and other infectionsDANA FARBER CANCER INST INC·Filed 2019·Application pending·0 cites
- 3446US2020360381A1Compounds for treating dengue virus infection and other viral infectionsDANA FARBER CANCER INST INC·Filed 2018·Application pending·0 cites
- 3544US2021340140A1Degradation of cyclin-dependent kinase 4/6 (cdk4/6) by conjugation of cdk4/6 inhibitors with e3 ligase ligand and methods of useDANA FARBER CANCER INST INC·Filed 2019·Application pending·0 cites
- 3640US10532103B2Degradation of cyclin-dependent kinase 9 (CDK9) by conjugation of CDK9 inhibitors with E3 ligase ligand and methods of useDANA FARBER CANCER INST INC·Filed 2017·Granted Jan 14, 2020·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when Nicholas Paul Kwiatkowski files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →